AT299449B - Verfahren zur herstellung von neuen, antibiotisch wirksamen benzdiazepin-verbindungen - Google Patents

Verfahren zur herstellung von neuen, antibiotisch wirksamen benzdiazepin-verbindungen

Info

Publication number
AT299449B
AT299449B AT1212169A AT1212169A AT299449B AT 299449 B AT299449 B AT 299449B AT 1212169 A AT1212169 A AT 1212169A AT 1212169 A AT1212169 A AT 1212169A AT 299449 B AT299449 B AT 299449B
Authority
AT
Austria
Prior art keywords
benzdiazepine
compounds
new
production
antibiotically effective
Prior art date
Application number
AT1212169A
Other languages
German (de)
English (en)
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP44050780A external-priority patent/JPS4843755B1/ja
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of AT299449B publication Critical patent/AT299449B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT1212169A 1968-12-30 1969-12-30 Verfahren zur herstellung von neuen, antibiotisch wirksamen benzdiazepin-verbindungen AT299449B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8369 1968-12-30
JP44050780A JPS4843755B1 (OSRAM) 1969-06-26 1969-06-26

Publications (1)

Publication Number Publication Date
AT299449B true AT299449B (de) 1972-05-15

Family

ID=26332993

Family Applications (1)

Application Number Title Priority Date Filing Date
AT1212169A AT299449B (de) 1968-12-30 1969-12-30 Verfahren zur herstellung von neuen, antibiotisch wirksamen benzdiazepin-verbindungen

Country Status (5)

Country Link
AT (1) AT299449B (OSRAM)
BE (1) BE743875A (OSRAM)
DE (1) DE1965304A1 (OSRAM)
FR (1) FR2027356A1 (OSRAM)
NL (1) NL6919607A (OSRAM)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9818731D0 (en) 1998-08-27 1998-10-21 Univ Portsmouth Compounds
GB9818730D0 (en) 1998-08-27 1998-10-21 Univ Portsmouth Collections of compounds
DK1193270T3 (da) 1998-08-27 2003-09-15 Spirogen Ltd Pyrrolobenzodiazepiner
GB9818732D0 (en) 1998-08-27 1998-10-21 Univ Portsmouth Collection of compounds
GB0226593D0 (en) 2002-11-14 2002-12-24 Consultants Ltd Compounds
GB0321295D0 (en) 2003-09-11 2003-10-15 Spirogen Ltd Synthesis of protected pyrrolobenzodiazepines
CA2558195C (en) 2004-03-01 2012-11-06 Spirogen Limited 11-hydroxy-5h-pyrrolo[2,1-c][1,4]benzodiazepin-5-one derivatives as key intermediates for the preparation of c2 substituted pyrrolobenzodiazepines
GB0404577D0 (en) 2004-03-01 2004-04-07 Spirogen Ltd Pyrrolobenzodiazepines
JP5166861B2 (ja) 2004-03-09 2013-03-21 スピロゲン リミティッド ピロロベンゾジアゼピン
GB0819095D0 (en) 2008-10-17 2008-11-26 Spirogen Ltd Pyrrolobenzodiazepines
CN102971329B (zh) 2010-04-15 2016-06-29 麦迪穆有限责任公司 用于治疗增殖性疾病的吡咯并苯并二氮杂卓
NZ602932A (en) 2010-04-15 2014-08-29 Seattle Genetics Inc Targeted pyrrolobenzodiazapine conjugates
GB201006340D0 (en) 2010-04-15 2010-06-02 Spirogen Ltd Synthesis method and intermediates
CN103987718A (zh) 2011-09-20 2014-08-13 斯皮罗根有限公司 作为非对称二聚体pbd化合物用于内含在靶向结合物中的吡咯并苯并二氮杂卓
CA2850103C (en) 2011-10-14 2019-09-10 Spirogen Sarl Pyrrolobenzodiazepines
US9388187B2 (en) 2011-10-14 2016-07-12 Medimmune Limited Pyrrolobenzodiazepines
JP6393617B2 (ja) 2011-10-14 2018-09-19 シアトル ジェネティクス,インコーポレーテッド ピロロベンゾジアゼピンおよび標的コンジュゲート
WO2013053872A1 (en) 2011-10-14 2013-04-18 Spirogen Sàrl Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines
CA2850375C (en) 2011-10-14 2019-07-02 Seattle Genetics, Inc. Pyrrolobenzodiazepines and targeted conjugates
EP2906250B1 (en) 2012-10-12 2018-05-30 ADC Therapeutics SA Pyrrolobenzodiazepine-anti-psma antibody conjugates
WO2014057073A1 (en) 2012-10-12 2014-04-17 Spirogen Sàrl Pyrrolobenzodiazepines and conjugates thereof
EP2906297B1 (en) 2012-10-12 2017-12-06 ADC Therapeutics SA Pyrrolobenzodiazepine-antibody conjugates
HRP20182129T1 (hr) 2012-10-12 2019-02-08 Adc Therapeutics Sa Konjugati protutijelo - pirolobenzodiazepin
LT2906251T (lt) 2012-10-12 2017-12-11 Adc Therapeutics Sa Pirolobenzodiazepino-anti-cd22 antikūno konjugatai
JP6392764B2 (ja) 2012-10-12 2018-09-19 エイディーシー・セラピューティクス・エス・アーAdc Therapeutics Sa ピロロベンゾジアゼピン−抗体結合体
HUE045435T2 (hu) 2012-10-12 2019-12-30 Medimmune Ltd Pirrolobenzodiazepinek és konjugátumaik
CA2885305C (en) 2012-10-12 2019-11-12 Spirogen Sarl Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation
JP6270859B2 (ja) 2012-10-12 2018-01-31 エイディーシー・セラピューティクス・エス・アー・エール・エルAdc Therapeutics Sarl ピロロベンゾジアゼピン−抗体結合体
WO2015052532A1 (en) 2013-10-11 2015-04-16 Spirogen Sàrl Pyrrolobenzodiazepine-antibody conjugates
GB201317981D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
US9950078B2 (en) 2013-10-11 2018-04-24 Medimmune Limited Pyrrolobenzodiazepine-antibody conjugates
US9956299B2 (en) 2013-10-11 2018-05-01 Medimmune Limited Pyrrolobenzodiazepine—antibody conjugates
GB201317982D0 (en) 2013-10-11 2013-11-27 Spirogen Sarl Pyrrolobenzodiazepines and conjugates thereof
GB201416112D0 (en) 2014-09-12 2014-10-29 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
EP3223854A1 (en) 2014-11-25 2017-10-04 ADC Therapeutics SA Pyrrolobenzodiazepine-antibody conjugates
GB201506411D0 (en) 2015-04-15 2015-05-27 Bergenbio As Humanized anti-axl antibodies
GB201506402D0 (en) 2015-04-15 2015-05-27 Berkel Patricius H C Van And Howard Philip W Site-specific antibody-drug conjugates
GB201601431D0 (en) 2016-01-26 2016-03-09 Medimmune Ltd Pyrrolobenzodiazepines
GB201602356D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201602359D0 (en) 2016-02-10 2016-03-23 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201607478D0 (en) 2016-04-29 2016-06-15 Medimmune Ltd Pyrrolobenzodiazepine Conjugates
GB201617466D0 (en) 2016-10-14 2016-11-30 Medimmune Ltd Pyrrolobenzodiazepine conjugates
KR20200032243A (ko) 2017-02-08 2020-03-25 에이디씨 테라퓨틱스 에스에이 피롤로벤조디아제핀-항체 컨주게이트
GB201702031D0 (en) 2017-02-08 2017-03-22 Medlmmune Ltd Pyrrolobenzodiazepine-antibody conjugates
SI3612537T1 (sl) 2017-04-18 2022-10-28 Medimmune Limited Konjugati pirolobenzodiazepina
EP3612234B1 (en) 2017-04-20 2024-03-13 ADC Therapeutics SA Combination therapy with an anti-axl antibody-drug conjugate
KR102442736B1 (ko) 2017-06-14 2022-09-16 에이디씨 테라퓨틱스 에스에이 항-cd19 adc의 투여를 위한 투약량 체제
CN111065638B (zh) 2017-08-18 2021-04-09 麦迪穆有限责任公司 吡咯并苯并二氮杂䓬缀合物
GB201803342D0 (en) 2018-03-01 2018-04-18 Medimmune Ltd Methods
GB201806022D0 (en) 2018-04-12 2018-05-30 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
IL286326B2 (en) 2019-03-15 2025-10-01 Medimmune Ltd Azatidobenzodiazepine dimers and conjugates containing them for use in the treatment of cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3361742A (en) * 1964-12-07 1968-01-02 Hoffmann La Roche 5-oxo-1h-pyrrolo-[2, 1-c][1, 4]-benzodiazepin-2-crylamides

Also Published As

Publication number Publication date
FR2027356B1 (OSRAM) 1974-01-11
DE1965304A1 (de) 1970-07-23
FR2027356A1 (en) 1970-09-25
BE743875A (OSRAM) 1970-05-28
NL6919607A (OSRAM) 1970-07-02

Similar Documents

Publication Publication Date Title
AT299449B (de) Verfahren zur herstellung von neuen, antibiotisch wirksamen benzdiazepin-verbindungen
AT301020B (de) Verfahren zur Herstellung von neuen α-Amino-cyclohexadienylalkylen-penicillinen und -cephalosporinen
AT301544B (de) Verfahren zur Herstellung von neuen Chromonen
CH513152A (de) Verfahren zur Herstellung von neuen Dibenz-oxepinen, -thiepinen und -azepinen
AT298451B (de) Verfahren zur Herstellung von neuen, basisch substituierten Phenolen
AT308981B (de) Verfahren zur Herstellung von neuen Perhydrobenzindenen
AT287198B (de) Verfahren zur Herstellung von neuen Penicillinen
CH558342A (de) Verfahren zur herstellung von neuen phenolderivaten.
AT295486B (de) Verfahren zur Herstellung von neuen Disulfiden
CH510668A (de) Verfahren zur Herstellung von neuen 1,6-Dimethyl-10a-ergolinderivaten
AT296276B (de) Verfahren zur Herstellung von neuen Indanderivaten
AT293425B (de) Verfahren zur Herstellung von neuen Bisammoniumverbindungen
AT293640B (de) Verfahren zur Herstellung von neuen Oxydo-cardadienoliden und -bufatrienoliden
AT284834B (de) Verfahren zur Herstellung von neuen Triazolyl-cumarinen
CH524630A (de) Verfahren zur Herstellung von neuen 2-Desoxyuridinen
CH525893A (de) Verfahren zur Herstellung von neuen Benzomorphanderivaten
CH514572A (de) Verfahren zur Herstellung von neuen Benzofuranderivaten
AT289296B (de) Verfahren zur Herstellung von neuen Penicillinen
CH505121A (de) Verfahren zur Herstellung von neuen Ammoniumverbindungen
AT309703B (de) Verfahren zur Herstellung von neuen 9α-unsubstituierten 11β-Chlor-19-norsteroiden
CH523256A (de) Verfahren zur Herstellung von neuen Bisimidazolyl-bisphenylmethanen
CH550202A (de) Verfahren zur herstellung von neuen cephalosporinverbindungen.
AT295144B (de) Verfahren zur Herstellung von neuen, überwiegend linearen Polybiureten
AT294311B (de) Verfahren zur Herstellung von neuen 2-Hydroxy-penamverbindungen
AT295760B (de) Verfahren zur Herstellung von neuen 2-Halogen-18-methyl-1-androstenen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee